Company
Atalanta Therapeutics
| Industry | developing RNA interference (RNAi) to treat neurological diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Atalanta Therapeutics | Series B | 2025-01-28 |
Company
| Industry | developing RNA interference (RNAi) to treat neurological diseases |
|---|
| Company | Round | Date |
|---|---|---|
| Atalanta Therapeutics | Series B | 2025-01-28 |